课题基金 / 基金详情

GLYCOSYLTRANSFERASES AS DRUG TARGETS IN MYCOBACTERIA

GLYCOSYLTRANSFERASES AS DRUG TARGETS IN MYCOBACTERIA
糖基转移酶作为分枝杆菌中的药物靶点
批准号:
6170333
负责人:
Robert C Reynolds
金额:
$40.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2003-08-31

项目摘要

项目成果

Robert C Reynolds的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Applicant's Abstract) Mycobacterial cell wall synthesis is a potential point of intervention in mycobacterial pathogenesis. The investigators will design and synthesize inhibitors of mycobacterial enzymes rhap and galf (neither are found in mammalian cells). Specifically, glycosyl donor and acceptor analogs of mycobacterial rhamnosyl- galactosyltransferases that utilize nucleoside diphosphate sugar donors UDP-galactofuranose and TDP-rhamnopyranose. Also, the investigators will make disaccharides that bind and inhibit in the acceptor site of the sugar transferases. These compounds will be screened in vitro using a broth dilution assay and cell-free assay transferase. Selected active compounds will be screened in vitro and in vivo in a macrophage assay and a murine TB model, respectively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A New Paradigm for HIV Treatment: Targeted Degradation of HIV Reverse Transcriptase via the Ubiquitin-Proteasome Pathway
A New Paradigm for HIV Treatment: Targeted Degradation of HIV Reverse Transcriptase via the Ubiquitin-Proteasome Pathway
Targeting MDR-TB
  • 批准号:
    7831362
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    Robert C Reynolds
  • 依托单位:
Targeting MDR-TB
  • 批准号:
    7936235
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    Robert C Reynolds
  • 依托单位:
海外基金